Concepedia

Publication | Open Access

Effects of soluble guanylate cyclase stimulator on renal function in ZSF-1 model of diabetic nephropathy

14

Citations

34

References

2022

Year

Abstract

The sGC stimulator Compound 1 as a monotherapy slowed renal disease progression, and a combination of the sGC stimulator with Enalapril provided greater renal protection in a rodent model of diabetic nephropathy.

References

YearCitations

Page 1